MARIANA CAMPELLO DE OLIVEIRA

Índice h a partir de 2011
1
Projetos de Pesquisa
Unidades Organizacionais
IPER, Hospital das Clínicas, Faculdade de Medicina - Médico

Resultados de Busca

Agora exibindo 1 - 3 de 3
  • article 1 Citação(ões) na Scopus
    Bariatric surgery and it influence in alcohol consumption-differences before and after surgery, a systematic review and meta-analysis
    (2023) VIDES, Mariana Capelo; OLIVEIRA, Mariana Campello de; LASSI, Dangela Layne Silva; MALBERGIER, Andre; FLORIO, Ligia; PERICO, Cintia de Azevedo-Marques; AMARAL, Ricardo Abrantes do; TORALES, Julio; VENTRIGLIO, Antonio; NEGRAO, Andre Brooking; CASTALDELLI-MAIA, Joao Mauricio
    BackgroundThrough new publications on the subject, the main goal of this article is to seek a change in the pattern of alcohol use before and after bariatric surgery.MethodsWe searched the National Library of Medicine, CINAHL, and PsycINFO databases. We included original articles regarding alcohol consumption before and after bariatric surgery to conduct the systematic review.ResultsOur systematic review, which included 18 articles, yielded mixed results. Meta-analysis of six articles did not reveal statistically significant differences in alcohol use behaviours before and one year after bariatric surgery. However, throughout the perspective of follow-up after bariatric surgery, nine out of the twelve articles showed improvement in the pattern of alcohol consumption when evaluated up to two years after the end of the surgical period, and four out of the five articles with monitoring beyond two years showed worsening in consumption, compared to pre-surgery alcohol use behaviours.ConclusionsConclusions about the relationship between alcohol consumption and bariatric surgery are challenging primarily because of the variety of the methods used and the alcohol consumption measures. Despite that, our research pointed to an increased risk of alcohol use disorders two years after bariatric surgery.
  • bookPart
    Dependência química no idoso
    (2023) OLIVEIRA, Mariana Campello de; VIDES, Mariana Capelo; MALBERGIER, André
  • article 4 Citação(ões) na Scopus
    Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review
    (2023) OLIVEIRA, Mariana Campello de; VIDES, Mariana Capelo; LASSI, Dangela Layne Silva; TORALES, Julio; VENTRIGLIO, Antonio; BOMBANA, Henrique Silva; LEYTON, Vilma; PERICO, Cintia de Azevedo-Marques; NEGRAO, Andre Brooking; MALBERGIER, Andre; CASTALDELLI-MAIA, Joao Mauricio
    (1) Background: Synthetic cannabinoids (SCs) are emerging drugs of abuse sold as 'K2', 'K9' or 'Spice'. Evidence shows that using SCs products leads to greater health risks than cannabis. They have been associated with greater toxicity and higher addiction potential unrelated to the primary psychoactive component of marijuana, & UDelta;9-tetrahydrocannabinol (& UDelta;9-THC). Moreover, early cases of intoxication and death related to SCs highlight the inherent danger that may accompany the use of these substances. However, there is limited knowledge of the toxicology of Spice ingredients. This systematic review intends to analyze the toxicity of SCs compounds in Spice/K2 drugs. (2) Methods: Studies analyzing synthetic cannabinoid toxicity and dependence were included in the present review. We searched the PubMed database of the US National Library of Medicine, Google Scholar, CompTox Chemicals, and Web of Science up to May 2022. (3) Results: Sixty-four articles reporting the effects of synthetic cannabinoids in humans were included in our review. Ten original papers and fifty-four case studies were also included. Fourteen studies reported death associated with synthetic cannabinoid use, with AB-CHMINACA and MDMB-CHMICA being the main reported SCs. Tachycardia and seizures were the most common toxicity symptoms. The prevalence of neuropsychiatric symptoms was higher in third-generation SCs. (4) Conclusion: SCs may exhibit higher toxicity than THC and longer-lasting effects. Their use may be harmful, especially in people with epilepsy and schizophrenia, because of the increased risk of the precipitation of psychiatric and neurologic disorders. Compared to other drugs, SCs have a higher potential to trigger a convulsive crisis, a decline in consciousness, and hemodynamic changes. Therefore, it is crucial to clarify their potential harms and increase the availability of toxicology data in both clinical and research settings.